← Leaderboards
Richard D Mamelok
Apricity Therapeutics, Inc.
$362,738
Attributed
$362,738
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $190K · FY2012–14$200K$150K$100K$50K$0
'12
'13
'14
Funding mix
By agency
NIH$362,738 · 2
By mechanism
R43$362,738 · 2
Top collaborators
No co-investigators on record.
Most similar at Apricity Therapeutics, Inc.
Same institution · by research overlap
- Huan-Chieh Chien$216,990
- Claire Brett$476,567
Others in their field
Top investigators on “Hepatotoxicity”
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Michael J. Detke · Embera Neurotherapeutics, Inc.$12,591,952
- Larry Arthur$10,844,376
- Aravind Asokan · Duke University$10,466,353
- Jose Szapocznik · University Of Miami School Of Medicine$10,384,857
- Brian S J Blagg · Scripps Research Institute$9,912,395
Research focus
HepatotoxicityLanguage DevelopmentDrug ToxicityHearing ImpairmentInfantKidneyDoseDrug Or Chemical Tissue DistributionGenerationsAnalogChemotherapy-Oncologic ProcedureChildInvestigational DrugsCisplatinAdverse EffectsCommercializationDrug KineticsCommunicationCytotoxicCell LineDeafnessDesignDiagnosisLead